Cost-effectiveness of initial therapy with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors to treat hypercholesterolemia in a primary care setting of a managed-care organization
- 1 May 1997
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 19 (3) , 582-602
- https://doi.org/10.1016/s0149-2918(97)80142-7
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Correlation of serum lipids with the presence or absence of coronary artery disease in 1,793 men and women aged ≥ 62 yearsThe American Journal of Cardiology, 1994
- Short- and Long-term Association of Serum Cholesterol with MortalityAmerican Journal of Epidemiology, 1992
- Cholesterol and coronary heart disease mortality. A 23-year follow-up study of 9902 men in Israel.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
- Is elevated serum cholesterol level a risk factor for coronary heart disease in the elderly?JAMA, 1990
- Plasma cholesterol, coronary heart disease, and cancer in the Renfrew and Paisley survey.BMJ, 1989
- SERUM CHOLESTEROL, BLOOD PRESSURE, AND MORTALITY: IMPLICATIONS FROM A COHORT OF 361 662 MENThe Lancet, 1986
- Plasma cholesterol concentration and death from coronary heart disease: 10 year results of the Whitehall study.BMJ, 1986
- Consensus conference. Lowering blood cholesterol to prevent heart diseasePublished by American Medical Association (AMA) ,1985
- Total and cardiovascular mortality in relation to cigarette smoking, serum cholesterol concentration, and diastolic blood pressure among black and white males followed up for five yearsAmerican Heart Journal, 1984
- Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart DiseaseAnnals of Internal Medicine, 1971